Development of a self-contained microfluidic chip and an internet-of-things-based point-of-care device for automated identification of respiratory viruses
Description
The COVID-19 pandemic greatly impacted the in vitro diagnostic market, leading to the development of new technologies such as point-of-care testing (POCT), multiplex testing, and digital health platforms. In this study, we present a self-contained
